Company intelligence / Profile preview

CenSyn

Scottsdale, Arizona, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

CenSyn is developing PenEEG, a pre-FDA, handheld EEG device and software platform intended for rapid (~2-minute), point-of-care brain health screening; as of 2024 it is pursuing clinical studies with clinicians to generate patient data and move toward FDA 510(k) clearance, but no pivotal or marketed clinical results have been reported yet.[2][5]

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapyDigital health platformTelehealth platform
Industry: Physiological Monitoring

Partnerships

HonorHealth (strategic partnership to deploy CenSyn’s portable brain health screening platform in clinical settings)[4]Arizona State University–associated funding and support (through Arizona state funding programs)[3]

Beyond the preview

Go deeper on CenSyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CenSyn.

Explore the full profile